Are you looking for expert advice...

Prescribing Medical Cannabis with Project Twenty21


Project Twenty21 is a registry aiming to monitor the health outcomes of 20,000 patients using cannabis based medicinal products (CBMPs), creating the largest body of evidence in Europe for the safety and efficacy of CBMPs.

Drug Science hope that the findings of Project Twenty21 will provide evidence for NHS funding where the benefits of treatment with medicinal cannabis is proven to outweigh the potential risks.

This real-world registry aims to target the following indications:

  • Anxiety Disorder
  • Chronic Pain
  • Multiple Sclerosis (MS)
  • Post-Traumatic Stress Disorder (PTSD)
  • Substance Use Disorder (as a harm reduction strategy)
  • Tourette’s Syndrome
  • Adult Epilepsy

Drug Science is actively looking to expand the number of clinics offering Project Twenty21 and to train more specialist clinicians to be able to prescribe medical cannabis in the UK.

If you would like to find out more about prescribing medical cannabis, please email [email protected] and a member of the T21 team will be in touch.

Prescribing with Twenty21

Prescribing as part of Twenty21

Clinician specialising in one of the seven indications listed here who and would like to find out more about prescribing medical cannabis should email [email protected] for more information.

News

News, case studies, clinician profiles and patient stories from the Medical Cannabis Clinicians Society.

Patient Stories

Patient Stories

Hear from patients benefiting from medical cannabis treatments in the UK.

Join the MCCS

Join the MCCS

Key reasons to join MCCS, a supportive clinical community growing by the day. Exclusive prescribing information, product details and peer support.

Society & Drug Science call for UK paediatricians to recognise the value of medical cannabis for childhood epilepsy – response to latest BPNA guidance
December 3, 2021

Society & Drug Science call for UK paediatricians to recognise the value of medical cannabis for childhood epilepsy – response to latest BPNA guidance

  The BPNA recently produced new guidance on the prescription of cannabis medicines for children with epilepsy. However, the Medical Cannabis Clinicians Society (UKMCCS) and Drug Science fundamentally disagree with…

Update guidance for 2021 – The Clinician’s Guide to CBD
October 19, 2021

Update guidance for 2021 – The Clinician’s Guide to CBD

The Medical Cannabis Clinicians Society's Guide to CBD has been newly updated for 2021. The expanded guidance supports doctors and clinicians who wish to understand how CBD works, what a…

BPNA’s rules deny safe treatment for children with epilepsy – an open letter to the Secretary of State for Health
October 4, 2021

BPNA’s rules deny safe treatment for children with epilepsy – an open letter to the Secretary of State for Health

Below is the text of an open letter which has been sent from the Medical Cannabis Clinicians Society to The Secretary of State for Health, Sajid Javid. Members of The…

Live, online training for Doctors with the Medical Cannabis Clinicians Society
January 14, 2021

Live, online training for Doctors with the Medical Cannabis Clinicians Society

Exclusively for members of The Medical Cannabis Clinicians Society, every two months doctors and medical students have the opportunity to attend a half-day, live and interactive Zoom training session with…